Medical Resource Consumption and Quality of Life in Peripheral Arterial Disease in Korea: PAD Outcomes PADO Research
- Authors
- Rha, Seung-Woon; Choi, Seung-Hyuk; Kim, Doo-Il; Jeon, Dong Woon; Lee, Jae-Hwan; Hong, Kyung-Soon; Cha, Tae-Joon; Cho, Jang-Hyun; Lee, Sang Kon; Park, Yong Hwan; Park, Woo Jung; Kim, Hyun-Joo; Kim, Young-Joo; Lee, Juneyoung; Choi, Donghoon
- Issue Date
- Sep-2018
- Publisher
- KOREAN SOC CARDIOLOGY
- Keywords
- Peripheral arterial disease; Disease burden; Quality of life
- Citation
- KOREAN CIRCULATION JOURNAL, v.48, no.9, pp.813 - 825
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- KOREAN CIRCULATION JOURNAL
- Volume
- 48
- Number
- 9
- Start Page
- 813
- End Page
- 825
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/73220
- DOI
- 10.4070/kcj.2017.0340
- ISSN
- 1738-5520
- Abstract
- Background and Objectives: We aimed to investigate the history of medical resource consumption and quality of life (QoL) in peripheral arterial disease (PAD) patients in Korea. Methods: This was a prospective, multi-center (23 tertiary-hospitals, division of cardiology non-interventional study. Adult patients (age >= 20 years) suffering from PAD for the last 12-month were enrolled in the study if they met with any of following; 1) ankle-brachial index (ABI) <= 0.9, 2) lower-extremity artery stenosis on computed tomography angiography >= 50%, or 3) peak-systolic-velocity-ratio (PSVR) on ultrasound >= 2.0. Medical chart review was used to assess patient characteristics/treatment patterns while the history of medical resource consumption and QoL data were collected using a patient survey. QoL was measured using EuroQoL-5-dimensions-3-level (EQ-5D-3L) score system, and the factors associated with QoL were analyzed using multiple linear regression analysis. Results: This study included 1,260 patients (age: 69.8 years, male: 77.0%). The most prevalent comorbidities were hypertension (74.8%), hyperlipidemia (51.0%) and diabetes mellitus (50.2%). The 94.1% of the patients took pharmacotherapy including aspirin (76.2%), clopidogrel (53.3%), and cilostazol (33.6%). The 12.6% of the patients were receiving smoking cessation education/pharmacotherapy. A considerable number of patients 500 patients, 40.0%) had visit history to another hospital before diagnosis/treatment at the current hospital, with visits to orthopedic units (50.4%) being the most common. At the time, 29% (or higher) of the patients were already experiencing symptoms of critical limb ischemia. Baseline EQ-SD index and EQ VAS were 0.64 +/- 0.24 and 67.49 +/- 18.29. Factors significantly associated with QoL were pharmacotherapy (B=0.05053; p=0.044) compared to no pharmacotherapy, and Fontaine stage improvement/maintain stage I (B=0.04448; p<0.001) compared to deterioration/maintain stage II-IV. Conclusions: Increase in disease awareness for earlier diagnosis and provision of adequate pharmacotherapy is essential to reduce disease burden and improve QoL of Korean PAD patients.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Biomedical Sciences > 1. Journal Articles
- College of Medicine > Department of Medical Science > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholar.korea.ac.kr/handle/2021.sw.korea/73220)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.